memantine.HCl

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Did a 29 year-old show GlaxoSmithKline that it made a billion dollar mistake?

29 year-old healthcare investor, Vivek Ramaswamy, bought an old Alzheimer's drug that GlaxoSmithKli

Pharma Chess: Strategies adopted in the United States to block generics

When a generic drug comes to the U.S. market, sales of brand drugs crash. The drop is more than 80%

Dr. Reddy’s expansion plans for API production

Unrelated to the inspection of the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe